These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26269033)

  • 1. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
    Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
    Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
    Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study.
    Yamashita H; Omori M; Takenaka R; Okuma K; Kobayashi R; Ohtomo K; Nakagawa K
    Radiother Oncol; 2014 Nov; 113(2):182-7. PubMed ID: 25466372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
    Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
    Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
    J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
    Jing Z; Chen T; Zhang X; Wu S
    Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.
    Li M; Zhang X; Zhao F; Luo Y; Kong L; Yu J
    Radiat Oncol; 2016 Feb; 11():18. PubMed ID: 26846932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis.
    Yamashita H; Okuma K; Wakui R; Kobayashi-Shibata S; Ohtomo K; Nakagawa K
    Radiother Oncol; 2011 Feb; 98(2):255-60. PubMed ID: 21074880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
    Kesarwala AH; Ko CJ; Ning H; Xanthopoulos E; Haglund KE; O'Meara WP; Simone CB; Rengan R
    Clin Lung Cancer; 2015 May; 16(3):237-44. PubMed ID: 25604729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
    Su J; Zhu S; Liu Z; Zhao Y; Song C
    Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study.
    Yamashita H; Takenaka R; Okuma K; Ootomo K; Nakagawa K
    Thorac Cancer; 2016 Sep; 7(5):564-569. PubMed ID: 27766787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
    Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.
    Kepka L; Bujko K; Zolciak-Siwinska A
    Acta Oncol; 2008; 47(1):95-103. PubMed ID: 17851862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study.
    Topkan E; Ozdemir Y; Guler OC; Kucuk A; Besen AA; Mertsoylu H; Sezen D; Akdemir EY; Sezer A; Bolukbasi Y; Pehlivan B; Selek U
    J Oncol; 2020; 2020():7083149. PubMed ID: 32952557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
    Han TJ; Kim HJ; Wu HG; Heo DS; Kim YW; Lee SH
    Jpn J Clin Oncol; 2012 Oct; 42(10):948-54. PubMed ID: 22811409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.
    Jing W; Zhu H; Guo H; Zhang Y; Shi F; Han A; Li M; Kong L; Yu J
    PLoS One; 2015; 10(12):e0143007. PubMed ID: 26636574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer.
    Ma JB; Song YP; Yu JM; Zhou W; Cheng EC; Zhang XQ; Kong L
    Onkologie; 2011; 34(11):599-604. PubMed ID: 22104156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.